Atrovent® inhalets

DRUG3 trials

Sponsors

Boehringer Ingelheim

Conditions

Pulmonary Disease, Chronic Obstructive

Unknown Phase

Postmarketing Surveillance of Atrovent® in Chronic Obstructive Pulmonary Disease

CompletedNCT02238158

Boehringer IngelheimPulmonary Disease, Chronic Obstructive

Start: 1999-09-30Updated: 2014-09-12

Postmarketing Surveillance Study of Atrovent® Inhalets in Chronic Obstructive Pulmonary Disease

CompletedNCT02238171

Boehringer IngelheimPulmonary Disease, Chronic Obstructive

Start: 2000-04-30Updated: 2014-09-12

Postmarketing Surveillance Study of Atrovent® Inhalets in Chronic Obstructive Airways Disease

CompletedNCT02238132

Boehringer IngelheimPulmonary Disease, Chronic Obstructive

Start: 1998-12-31Updated: 2014-09-12